On April 28, 2025, IceCure Medical Ltd. announced its participation at the Society of Breast Imaging (SBI) 2025 Breast Imaging Symposium, which took place from April 24-27, 2025, in Colorado Springs, Colorado. IceCure was a sponsor of the SBI Breast Cryoablation courses, where two sold-out classes were conducted for hands-on training with the ProSense® system. This indicates a growing interest among radiologists in integrating ProSense® into their clinical practices.
The sold-out courses, led by the SBI, demonstrate that an increasing number of medical societies are adopting cryoablation into their curriculum. At its booth, IceCure hosted a VIP Exhibitor Hour with Dr. Robert Ward, a ProSense® user and Assistant Professor of Diagnostic Imaging at Brown University, who specializes in women's imaging and breast tumor cryoablation. Participants learned about the rationale and techniques behind breast cryoablation and discussed growing clinical data.
IceCure's CEO, Eyal Shamir, stated that the company's mission aligns with SBI's focus on early detection and treatment to minimize breast cancer impact. Showcasing ProSense® to thousands of SBI society physicians in the U.S. is crucial as the company anticipates potential regulatory clearance for breast cancer in the U.S., aiming to provide a quick and minimally invasive option for tumor destruction.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.